These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26334290)

  • 21. Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens.
    Hwang SM; Lim MS; Hong YJ; Kim TS; Park KU; Song J; Lee JH; Kim EC
    Tuberculosis (Edinb); 2013 Nov; 93(6):642-6. PubMed ID: 23988279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
    Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea.
    Kim SY; Kim CK; Bae IK; Jeong SH; Yim JJ; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Kang YA
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):107-11. PubMed ID: 25467784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana.
    Addo KK; Addo SO; Mensah GI; Mosi L; Bonsu FA
    BMC Infect Dis; 2017 Dec; 17(1):743. PubMed ID: 29197331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
    Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
    J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense.
    Zhang Z; Lu J; Liu M; Wang Y; Zhao Y; Pang Y
    Int J Antimicrob Agents; 2017 Mar; 49(3):383-386. PubMed ID: 28188830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J; Wang F; Hong CY; Li JL; Liang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug susceptibility patterns of rapidly growing mycobacteria isolated from skin and soft tissue infections in Venezuela.
    Da Mata-Jardín O; Angulo A; Rodríguez M; Fernández-Figueiras S; de Waard JH
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):433-441. PubMed ID: 31741101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41).
    Maurer FP; Rüegger V; Ritter C; Bloemberg GV; Böttger EC
    J Antimicrob Chemother; 2012 Nov; 67(11):2606-11. PubMed ID: 22833642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Mycobacterium abscessus complex and M. abscessus subsp. massiliense culture isolates by real-time assays.
    Syrmis MW; Pandey S; Tolson C; Carter R; Congdon J; Sloots T; Coulter C; Whiley D
    J Med Microbiol; 2015 Jul; 64(7):790-794. PubMed ID: 25976000
    [No Abstract]   [Full Text] [Related]  

  • 31. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
    Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ
    Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.
    Park J; Cho J; Lee CH; Han SK; Yim JJ
    Clin Infect Dis; 2017 Feb; 64(3):301-308. PubMed ID: 28011609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients.
    Cândido PH; Nunes Lde S; Marques EA; Folescu TW; Coelho FS; de Moura VC; da Silva MG; Gomes KM; Lourenço MC; Aguiar FS; Chitolina F; Armstrong DT; Leão SC; Neves FP; Mello FC; Duarte RS
    J Clin Microbiol; 2014 Aug; 52(8):2990-7. PubMed ID: 24920766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the population structure of Mycobacterium abscessus complex strains using 17-locus variable number tandem repeat typing and the further distinction of Mycobacterium massiliense hsp65 genotypes.
    Yoshida S; Arikawa K; Tsuyuguchi K; Kurashima A; Harada T; Nagai H; Suzuki K; Iwamoto T; Hayashi S
    J Med Microbiol; 2015 Mar; 64(Pt 3):254-261. PubMed ID: 25596119
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic susceptibility of diverse Mycobacterium abscessus complex strains in New South Wales, Australia.
    Chua KY; Bustamante A; Jelfs P; Chen SC; Sintchenko V
    Pathology; 2015 Dec; 47(7):678-82. PubMed ID: 26517625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and assessment of clarithromycin inducible resistant strains among Korean Mycobacterium abscessus clinical strains: PCR methods.
    Lee SH; Yoo HK; Kim SH; Koh WJ; Kim CK; Park YK; Kim HJ
    J Clin Lab Anal; 2014 Sep; 28(5):409-14. PubMed ID: 24652818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
    Guglielmetti L; Mougari F; Lopes A; Raskine L; Cambau E
    Future Microbiol; 2015; 10(9):1467-83. PubMed ID: 26344005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
    Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
    Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing?
    Hanson KE; Slechta ES; Muir H; Barker AP
    J Clin Microbiol; 2014 May; 52(5):1705-7. PubMed ID: 24554745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.